<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00449332</url>
  </required_header>
  <id_info>
    <org_study_id>14516A</org_study_id>
    <nct_id>NCT00449332</nct_id>
  </id_info>
  <brief_title>Early Indicators of Chronic Rejection in Lung Transplant</brief_title>
  <acronym>BOS</acronym>
  <official_title>Role of Inflammatory and Fibroproliferative Cytokines in the Pathogenesis of Bronchiolitis Obliterans Syndrome-OP in Lung Transplant Recipients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to discover the different patterns of cytokine production in&#xD;
      patients who may develop Bronchiolitis Obliterans Syndrome-0p (BOS-0p) which means ongoing&#xD;
      rejection. This is an early indicator of chronic rejection in lung transplant recipients.&#xD;
      These cytokines can be detected in the bronchoalveolar (lung) and tissue samples of lung&#xD;
      transplant recipients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lung transplant recipients are routinely followed in clinic every three months after the&#xD;
      first year post-transplant. Spirometry with measurement of FEV1, FVC and FEF25-75 are&#xD;
      obtained at each visit. In addition, lung transplant recipients undergo surveillance&#xD;
      bronchoscopy at one, three, six, nine and twelve months. All bronchoscopy specimens that are&#xD;
      obtained for this study will be obtained during bronchoscopies that were scheduled per the&#xD;
      physician caring for the patient. An extra 90 cc of sterile solution will be instilled into&#xD;
      bronchus and two extra transbronchial biopsies will be performed in addition to the routine&#xD;
      bronchoscopic procedure. Routinely, 4-8 transbronchial biopsy samples are obtained from the&#xD;
      transplanted lung. Two specimens will be randomly selected for study and the rest will&#xD;
      undergo routine histopathologic study. The study biopsies will be set aside and processed.&#xD;
      The study visits for this research will occur at the same time as standard of care post&#xD;
      transplant visits. We will collect subject's history,demographic of subject's transplant&#xD;
      data,donor procurement information, physical exam information, pregnancy tests,blood test and&#xD;
      spirometry results from the visits mentioned above.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    PI left University&#xD;
  </why_stopped>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>cytokines, chemokines and T cell subsets associated with BOS</measure>
    <time_frame>12/2013</time_frame>
  </primary_outcome>
  <enrollment type="Actual">120</enrollment>
  <condition>Chronic Rejection in Lung Transplant</condition>
  <condition>Cytokine Production in Bos Post Lung Transplant</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      lung tissues, bal, blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Post lung transplant patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Lung transplant recipients between the ages of 18 and 65 years old&#xD;
&#xD;
          -  All patients must be able to give written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Lung transplant recipients who are unable to undergo bronchoscopy&#xD;
&#xD;
          -  Lung transplant recipients who are unable to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sangeeta M Bhorade, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <study_first_submitted>March 16, 2007</study_first_submitted>
  <study_first_submitted_qc>March 16, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2007</study_first_posted>
  <last_update_submitted>September 19, 2016</last_update_submitted>
  <last_update_submitted_qc>September 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic rejection, lung transplant, cytokines, bos</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

